Cargando…
Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer’s disease:a systematic review with meta-analysis
OBJECTIVE: Amyloid-β positron emission tomography (Aβ-PET) scan has been proposed to detect amyloid-β (Aβ) deposition in the brain. However, this approach is costly and not ideal for the early diagnosis of Alzheimer’s disease. Blood-based Aβ measurement offers a scalable alternative to the costly or...
Autores principales: | Cheng, Lizhen, Li, Wei, Chen, Yixin, Lin, Yijia, Wang, Beiyun, Guo, Qihao, Miao, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016262/ https://www.ncbi.nlm.nih.gov/pubmed/35241627 http://dx.doi.org/10.1136/jnnp-2021-327864 |
Ejemplares similares
-
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition
por: Rauchmann, Boris Stephan, et al.
Publicado: (2021) -
Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic
por: Altomare, Daniele, et al.
Publicado: (2023) -
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022) -
CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020) -
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)